Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now X
ETFs with SHPG as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|4.54%||WBI SMID Tactical Growth Shares (WBIA)||+0.23 (0.92%)|
|3.65%||WBI Large Cap Tactical Value Shares (WBIF)||-0.41 (-1.69%)|
|2.04%||WBI SMID Tactical Value Shares (WBIB)||+0.56 (2.33%)|
|1.9%||iShares Nasdaq Biotechnology Index Fund (IBB)||+54.10 (17.00%)|
Company Description (as filed with the SEC)
Shire plc and its subsidiaries (collectively referred to as either "Shire", or the "Company") is a leading biopharmaceutical company that focuses on developing and marketing innovative medicines for patients with rare diseases and other specialty conditions. The Company has grown both organically and through acquisition, completing a series of major transactions that have brought therapeutic, geographic and pipeline growth and diversification. The Company will continue to conduct its own research and development ("R&D"), focused on rare diseases, as well as evaluate companies, products and pipeline opportunities that offer a strategic fit and have the potential to deliver value to all of the Company's stakeholders: patients, physicians, policy makers, payers, investors and employees. Strategy Shire's purpose is to enable people with life altering conditions to lead better lives. ... More ...
Where does SHPG fit in the risk graph?
|Annual EPS Est:||$10.6|
|Quarterly EPS Est:||2.82|